Journals / İstanbul Kanuni Sultan Süleyman Tıp Dergisi / 2014 / Cilt: 6 - Sayı: 3

Infantil Urolithiasis: A Single Center Experience

İnfantil Ürolitiyazis: Tek Merkez Deneyimi

Pages
137–141
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The susceptibility to UL in infants.might be considered while recommending the usage of vitamin D.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The etiological and clinical features of urolithiasis (UL) in infants were evaluated.Material and Methods: The study included 150 infants who were diagnosed as UL before 1 year of age.
📊
Key Findings & Data:Demographic, radiological and laboratory data of the patients were retrospectively recorded.Results: The dimensions of the stones were below 3 mm in 43.3 % and over 3 mm in 56.7 % of the patients.
💡
Conclusion & Impact:The susceptibility to UL in infants.might be considered while recommending the usage of vitamin D.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The etiological and clinical features of urolithiasis (UL) in infants were evaluated.Material and Methods: The study included 150 infants who were diagnosed as UL before 1 year of age. Demographic, radiological and laboratory data of the patients were retrospectively recorded.Results: The dimensions of the stones were below 3 mm in 43.3 % and over 3 mm in 56.7 % of the patients. The main symptoms were abdominal pain and disturbance (36 %). The prematurity was recorded in 14.7 %, family history in 46.7 % of the patients. while 13 % of them had additional urinary abnormalities. Besides, 15 % of them had urinary tract infections (UTIs), and 51.3 % had an underlying metabolic abnormality. The most common metabolic disturbance was hypercalciuria. Almost half of the patients used vitamin D and 10 % of them had high vitamin D levels. The stones were completely resolved in 62.7 % of the patients. The dimensions of the stones decreased in 34 %, whereas increased in 3.3 % of the participants.Conclusion: Infants should be carefully examined for the probable underlying metabolic, infectious or additional urinary abnormalities. The susceptibility to UL in infants.might be considered while recommending the usage of vitamin D.

Özet

Amaç: İnfantlarda ürolitiyazisin (UL) etiyolojik ve klinik özelliklerini değerlendirildi. Gereç ve Yöntem: Bir yaş altında UL tanısı alan 150 hasta çalışmaya alındı. Hastaların demografik, radyolojik ve laboratuvar bilgileri retrospektif olarak kaydedildi.Bulgular: Hastaların % 43.3'ünde taş boyutu 3 mm ve altında, % 56.7'sinde 3 mm'nin üzerindeydi. En sık başvuru yakınması karın ağrısı ve huzursuzluktu (% 36). Hastaların % 14.7'sinde prematürite, % 46.7'sinde ailede taş öyküsü saptandı. Ek üriner sistem anomalisi % 13, idrar yolu enfeksiyonu (İYE) % 15, metabolik bozukluk % 51.3 oranında görüldü. En sık metabolik neden hiperkalsiüri idi. Hastaların yaklaşık yarısında D vitamini kullanımı ve % 10'unda serum vitamin D düzeyi yüksekliği mevcuttu. Hastaların % 62.7'sinde taşlar tamamen kaybolurken, % 34'ünde taş boyutlarında azalma, % 3.3'ünde ise artma gözlendi.Sonuç: Üriner sistem taş hastalığı saptanan bebekler altta yatabilecek metabolik, enfeksiyöz nedenler ya da ek üriner anomali yönünden dikkatli değerlendirilmelidir. Süt çocuklarında rutin D vitamini önerirken taşa yatkınlık riski de göz önünde bulundurulabilir.

🔖

Cite This Article

DEMİR, F., KIYAK, A., YAVUZ, S., AYDOĞAN, G., SARI, F., KORKMAZ, O. (2022). Infantil Urolithiasis: A Single Center Experience. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, Cilt: 6 - Sayı: 3, 137–141. https://ajindex.com/articles/551169

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Spivacow FR, Negri AL, del Valle EE et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008;23:1129-33.
  2. Stamatelou KK, Francis ME, Jones CA. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817-23.
  3. Ali SH, Rifat UN. Etiological and clinical patterns of childhood urolithiasis in Iraq. Pediatr Nephrol 2005; 20:1453-7.
  4. Coward RJ, Peters CJ, Duffy PG, Corry D, Kellett MJ, Choong S, van't Hoff WG. Epidemiology of paediatric renal Stone disease in UK. Arch Dis Child 2003;88:962-5.
  5. Dursun I, Poyrazoglu HM, Dusunsel R, Gunduz Z, Gurgoze MK, Demirci D, Kucukaydin M. Pediatric urolithiasis: an 8-year experience of single centre. Int Urol Nephrol 2008;40:3-9.
  6. VanDervoort K, Wiesen J, Frank R et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 2007;177: 2300-5.
  7. Lopez M, Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol 2010;25: 49-59.
  8. Polito C, Cioce F, La Manna A, Maiello R, Di Toro R. Renal calyceal microlithiasis: clinical presentation may precede sonographic evidence. Clin Pediatr (Phila) 1999;38:521-4.
  9. Alon US, Srivastava T. Urolithiasis. In: Kher KK, Schnaper HW, Makker SP (eds). Clinical Pediatric Nephrology, 2nd Ed. Informa UK Ltd 2007;539-51
  10. Gillespie RS, Stapleton FB. Nephrolithiasis in children. Pediatr Rev 2004;25:131-9.
  11. Mohamed J, Riadh M, Abdellatif N. Urolithiasis in infants. Pediatr Surg Int 2007;23:295-9.
  12. Alon US, Zimmerman H, Alon M. Evaluation and treatment of pediatric idiopathicurolithiasis-revisited. Pediatr Nephrol 2004;19:516-20.
  13. Ozokutan BH, Küçükaydın M, Gündüz Z, Kabaklı- oğlu M, Okur H, Turan C. Urolihiasis in childhood. Pediatr Surg Int 2000;16:60-3.
  14. Narendra A, White PM, Rolton AH, Alloub ZI, Wilkinson G, McColl JH, Beattie J. Nephrocalcinosis in preterm babies. Arch Dis Fetal Neonat